RESEARCH-USE BIOSIMILAR ANTIBODY

Idactamab

Antibody-drug conjugate · IgG1

SLC1A5IgG1RUO

Idactamab (INT-001) is an IgG1-κ antibody with in vivo activity across a spectrum of hematological malignancies. Idactamab can be used for prepare MEDI7247, a potent and specific ADC, targeting ASCT2 (SLC1A5).

TARGETSLC1A5
YAntibody-drug conjugate
CATALOGSC-BS-485
CATALOG NUMBERSC-BS-485
MOLECULAR WEIGHTApprox. 146.54 kDa
PRODUCT FORMATAntibody-drug conjugate

A research-use configuration for comparative antibody studies

Idactamab (INT-001) is an IgG1-κ antibody with in vivo activity across a spectrum of hematological malignancies. Idactamab can be used for prepare MEDI7247, a potent and specific ADC, targeting ASCT2 (SLC1A5).

Idactamab is a recombinant research-use antibody directed against SLC1A5.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte